IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced that, following its previous announcement regarding its decision to explore the introduction of additional business activities, it has entered into a non-binding letter of intent (the "LOI") to acquire 51% of Blackaxe Technologies Spolka z Organiczona ("Blackaxe"), a Polish technology company specializing in advanced defense and intelligence solutions.

The proposed transaction represents a potential strategic expansion for IMC into the defense and homeland security technology sectors.

Black Axe operates in various defense segments including satellite intelligence, imagery and AI analytics, and counter-UAS (anti-drone) solutions based on cyber interception technologies. Black Axe's activities are based on advanced Israeli technologies designed to support governments, defense organizations and security agencies in addressing evolving aerial and intelligence threats.

The proposed transaction takes place against the backdrop of a rapidly expanding global defense and security market driven by rising geopolitical tensions and the proliferation of new threats such as low-cost drones and advanced missile systems. Current conflicts in Eastern Europe and the Middle East have accelerated demand for satellite intelligence, real-time analytics, and counter-drone technologies, which are becoming critical capabilities for both military forces and homeland security agencies.

The proposed transaction is subject to completion of due diligence, execution of definitive agreements and customary closing conditions and regulatory approvals. There can be no assurance that the parties will enter into a definitive agreement or that the proposed transaction will be completed.